PARP inhibition induces synthetic lethality and adaptive immunity in LKB1-mutant lung cancer. Long LL, Ma SC, Guo ZQ, Zhang YP, et al. Cancer Res 2022 Dec 13:CAN-22-1740. doi: 10.1158/0008-5472.CAN-22-1740.

Read + Share

Amedeo Smart

Independent Medical Education

Long LL, Ma SC, Guo ZQ, Zhang YP, et al. PARP inhibition induces synthetic lethality and adaptive immunity in LKB1-mutant lung cancer. Cancer Res 2022 Dec 13:CAN-22-1740. doi: 10.1158/0008-5472.CAN-22-1740.
PMID: 36512628